Granules India Q4FY26 revenue jumps 23% to Rs 14,706 million; FY26 revenue at Rs 53,656 million
The figures highlight double-digit revenue growth, margin expansion, and continued momentum in complex generics and peptides CDMO platform
The figures highlight double-digit revenue growth, margin expansion, and continued momentum in complex generics and peptides CDMO platform
On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
Subscribe To Our Newsletter & Stay Updated